Parkinson's drug study halted early: what happened?
Disease control
Terminated
This study tested a drug called minzasolmin (UCB0599) in 428 people with early Parkinson's disease to see if it could slow brain changes over time. Participants were split into groups that started the drug early or later. The study was terminated early, so results are limited. It…
Phase: PHASE2 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 15, 2026 11:55 UTC